It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2022.
2022 | Hyderabad, Telangana, India | ActiveSpansules Formulations India Private Limited, a active private limited company, was established on 09 March 2022 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG2022PTC160441. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.54 Cr.
Employing 57 professional, Its leadership includes Rama Devi Guttikonda (Director), Haswanth Rao Guttikonda (Director), Harika Rao Guttikonda (Director). It holds ₹33.01 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor Mig-57,Dharma Reddy Colony Hyder Nagar,Kukatpally, Hyderabad, Telangana, 500072.
U24230TG2022PTC160441
160441
09 March 2022
₹10.00 Cr
₹9.54 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Spansules Formulations India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Devi Guttikonda | Director | 09 Mar 2022 | Current |
| Haswanth Rao Guttikonda | Director | 09 Mar 2022 | Current |
| Harika Rao Guttikonda | Director | 09 Mar 2022 | Current |
| Venkata Subba Rao Guttikonda | Director | 09 Mar 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spansules Formulations India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Spansules Formulations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹330,057,971.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jul 2025 | Hdfc Bank Limited | ₹1.12 Cr | Open |
| 12 Jan 2024 | Hdfc Bank Limited | ₹1.50 M | Open |
| 25 May 2023 | Axis Bank Limited | ₹2.50 Cr | Open |
| 01 Oct 2022 | Hdfc Bank Limited | ₹28.44 Cr | Open |
| 10 Jun 2022 | Hdfc Bank Limited | ₹8.01 M | Open |
Explore comprehensive loan charge details -
Spansules Formulations India has a workforce of 57 employees as of Oct 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spansules Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansules Formulations India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 1.12 Cr with Charge ID 101130960 was registered on 14 Jul 2025. was completed.
Spansules Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Spansules Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100862495 was registered on 12 Jan 2024. was recorded as a recent event.
A charge with Axis Bank Limited amounted to Rs. 2.50 Cr with Charge ID 100725614 was registered on 25 May 2023. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 28.44 Cr registered on 01 Oct 2022 with Charge ID 100629886 was modified on 21 Apr 2023. was recorded as a recent event.
The CIN of Spansules Formulations India Private Limited is U24230TG2022PTC160441.
Spansules Formulations India Private Limited is headquartered at 3Rd Floor Mig-57,Dharma Reddy Colony Hyder Nagar,Kukatpally, Hyderabad, Telangana, 500072.
Spansules Formulations India Private Limited was incorporated on 09 March 2022.
The current directors of Spansules Formulations India Private Limited are
The primary industry of Spansules Formulations India Private Limited is Manufacturing.
Spansules Formulations India Private Limited is unlisted.
The authorized capital of Spansules Formulations India Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.54 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX